The Administrative and Advocacy Core will provide organizational and financial oversight of all projects and cores. This resource will assure that all administrative requirements for a successful completion of the overall SPORE goals are met. It will provide the logistics necessary for development and support of all projects, cores, and programs, and it will integrate patient advocacy as a vital component for laboratory and clinical lung cancer research. The Core includes personnel who are not specifically listed or budgeted for in individual research projects. However, this personnel are vital to the successful function of the SPORE as a whole, and are required across all projects. The external advisors are: John Crowley, Ph.D., Professor of Biostatistics, University of Washington, Seattle, Washington;Lead statistician for the Southwest Oncology Group. Adi Gazdar, M.D., Professor of Pathology, University of Texas Southwestern Medical Center in Dallas, Texas. Jonathan Kurie, M.D., Professor of Medicine, MD Anderson Cancer Center in Houston, Texas. Joseph Nevins, Ph.D., Howard Hughes Investigator, James B. Duke Professor of Genetics, Chairman of the Department of Genetics, Duke University Medical Center, Durham, North Carolina. David Rimm, M.D., Ph.D., Associate Professor of Pathology, Department of Pathology, Yale University, New Haven, Connecticut. Joan Schiller, M.D., Professor of Medicine, Chief, Division of Hematology and Medical Oncology at the University of Texas Southwestern Medical Center in Dallas, Texas. Jeffrey S. Weber, M.D., Ph.D., Professor of Medicine and Microbiology, Chief of the Division of Hematology and Medical Oncology at the University of Southern California in Los Angeles, California.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA119997-03
Application #
8118137
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2010-09-01
Budget End
2011-08-31
Support Year
3
Fiscal Year
2010
Total Cost
$218,717
Indirect Cost
Name
H. Lee Moffitt Cancer Center & Research Institute
Department
Type
DUNS #
139301956
City
Tampa
State
FL
Country
United States
Zip Code
33612
Ferreiro-Iglesias, Aida; Lesseur, Corina; McKay, James et al. (2018) Fine mapping of MHC region in lung cancer highlights independent susceptibility loci by ethnicity. Nat Commun 9:3927
Li, Yafang; Xiao, Xiangjun; Han, Younghun et al. (2018) Genome-wide interaction study of smoking behavior and non-small cell lung cancer risk in Caucasian population. Carcinogenesis 39:336-346
Li, Qian; Balagurunathan, Yoganand; Liu, Ying et al. (2018) Comparison Between Radiological Semantic Features and Lung-RADS in Predicting Malignancy of Screen-Detected Lung Nodules in the National Lung Screening Trial. Clin Lung Cancer 19:148-156.e3
Ctortecka, Claudia; Palve, Vinayak; Kuenzi, Brent M et al. (2018) Functional Proteomics and Deep Network Interrogation Reveal a Complex Mechanism of Action of Midostaurin in Lung Cancer Cells. Mol Cell Proteomics 17:2434-2447
Ji, Xuemei; Bossé, Yohan; Landi, Maria Teresa et al. (2018) Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk. Nat Commun 9:3221
Rosenberger, Albert; Hung, Rayjean J; Christiani, David C et al. (2018) Genetic modifiers of radon-induced lung cancer risk: a genome-wide interaction study in former uranium miners. Int Arch Occup Environ Health 91:937-950
Dai, Juncheng; Li, Zhihua; Amos, Christopher I et al. (2018) Systematic analyses of regulatory variants in DNase I hypersensitive sites identified two novel lung cancer susceptibility loci. Carcinogenesis :
Li, Qian; Kim, Jongphil; Balagurunathan, Yoganand et al. (2017) Imaging features from pretreatment CT scans are associated with clinical outcomes in nonsmall-cell lung cancer patients treated with stereotactic body radiotherapy. Med Phys 44:4341-4349
Gimbrone, Nicholas T; Sarcar, Bhaswati; Gordian, Edna R et al. (2017) Somatic Mutations and Ancestry Markers in Hispanic Lung Cancer Patients. J Thorac Oncol 12:1851-1856
Lohavanichbutr, Pawadee; Sakoda, Lori C; Amos, Christopher I et al. (2017) Common TDP1 Polymorphisms in Relation to Survival among Small Cell Lung Cancer Patients: A Multicenter Study from the International Lung Cancer Consortium. Clin Cancer Res 23:7550-7557

Showing the most recent 10 out of 108 publications